• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
About Us Contact Us Login ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
Grand Rounds

ANODE RCT Results: Antibiotic Prophylaxis for Forceps or Vacuum Extraction?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Evidence is limited as to whether antibiotics are beneficial for operative deliveries
  • Knight et al. (Lancet, 2019) investigated whether antibiotic prophylaxis was effective at preventing maternal infection following operative vaginal birth

METHODS:

  • Blinded, randomized controlled trial (RCT)
    • Prophylactic ANtibiotics in the prevention of infection after Operative vaginal DElivery (ANODE) trial
  • Participants
    • ≥16 years who had undergone operative vaginal birth at ≥36 weeks
    • Any type of operative delivery included
      • Any type of instrument
      • Whether or not rotation used
      • Any station of the fetal head at the time of instrument application
  • Exposure
    • Single dose IV: 1 g amoxicillin and 200 mg clavulanic acid
    • Administered as soon as possible and no more than 6 h after giving birth
  • Primary outcome
    • Confirmed or suspected maternal infection within 6 weeks of delivery defined by
      • A new prescription of antibiotics for perineal wound infection | UTI | Confirmed systemic infection on culture | Endometritis
  • Secondary outcomes included
    • Systemic sepsis | perineal wound infection | Perineal pain | Use of pain relief | Length of stay | Need for additional perineal care | Dyspareunia
    • Antibiotic side effects
    • Healthcare costs
  • Analysis
    • To detect 50% difference with 90% statistical power, 1,712 women would be required per arm if taking in to account a 5% loss to follow-up
    • Intention-to-treat analysis

RESULTS:

  • 3,420 women
    • 1,715 in antibiotic group | 1,705 in placebo group
    • Primary outcome data were missing for 6% of women (195 women)
  • Significantly fewer women in the amoxicillin and clavulanic acid group had confirmed or suspected infection
    • 11% of amoxicillin and clavulanic acid group
    • 19% of placebo group
    • Risk ratio (RR) 0.58, (95% CI, 0.49–0.69; p<0.0001)
  • Intervention benefit was also seen at 6 weeks post-delivery with significantly lower proportion of women affected with the following secondary outcomes
    • Perineal infection | Perineal pain | Use of pain relief for perineal pain | Need for additional perineal care | Wound breakdown
  • Post-hoc analysis looking at forceps and vacuum separately
    • In both forceps and vacuum, number of women with infection was reduced by approximately 50%
  • Adverse reactions
    • Amoxicillin and clavulanic acid: 2 women had allergic reactions, one serious
    • Placebo: 1 woman had a skin rash
    • Two other serious adverse events were reported, but neither was considered to be caused by the treatment

CONCLUSION:

  • Antibiotic prophylaxis reduced risk of maternal infection following operative vaginal birth
  • The authors conclude

…this trial shows clear benefit of a single dose of prophylactic antibiotic after operative vaginal birth, and guidance should be changed to reflect this finding.

Learn More – Primary Sources:

Prophylactic antibiotics in the prevention of infection after operative vaginal delivery (ANODE): a multicentre randomised controlled trial

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

Learn More  »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Cesarean Delivery Best Practices & Guidelines – The ERAS Committee Recommendations
Forceps/Vacuum Delivery vs Cesarean Section and Adverse Maternal and Perinatal Outcomes
Mode of Delivery and Risk of Pelvic Floor Disorders, Quantified Over Time
Azithromycin Prophylaxis to Reduce Infection Risk Post C-Section

Sections

  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • COVID-19

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site